More on VRTX
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $347.04 |
|
|||
| Open | $347.50 | ||||
| 52 Wk High | $134.71 | ||||
| 52 Wk Low | $73.31 | ||||
| Day High | $353.60 | ||||
| Day Low | $346.68 | ||||
| P/E | N/A | ||||
| EPS | $-1.98 | ||||
| Volume | 1,497,311 | ||||
- Vertex Pharma (VRTX) Announces Health Canada Has Granted Market Authorization for the Expanded Use of Kalydeco
- Vertex Pharma (VRTX) Announces EMA Validation for Marketing Authorization Application Extension for KAFTRIO in Combination With Ivacaftor
- Vertex Announces European Medicines Agency Validation for Marketing Authorization Application Extension for KAFTRIO® in Combination With Ivacaftor to Include People With Cystic Fibrosis and Responsiv
- Vertex Pharma (VRTX) Announces EU Approval of KAFTRIO in Combination With Ivacaftor for the Treatment of Children With Cystic Fibrosis Ages 2 Through 5
- European Commission Approves KAFTRIO® in Combination With Ivacaftor for the Treatment of Children With Cystic Fibrosis Ages 2 Through 5
- Form 4 VERTEX PHARMACEUTICALS For: Nov 20 Filed by: WAGNER CHARLES F JR
- Form 144 VERTEX PHARMACEUTICALS Filed by: WAGNER CHARLES F JR
- Vortex Energy Announces Commencement of Drilling Program at Robinsons River Salt Project, Newfoundland & Labrador
- Form 4 VERTEX PHARMACEUTICALS For: Nov 15 Filed by: Sachdev Amit
- Form 4 VERTEX PHARMACEUTICALS For: Nov 15 Filed by: ALTSHULER DAVID
Entities mentioned with VRTX
- Earnings | View Related Stories »
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Definitive Agreement | View Related Stories »
- Needham & Company | View Related Stories »
- Morgan Stanley | View Related Stories »
- Jefferies & Co | View Related Stories »
- JPMorgan | View Related Stories »
- Show More...
